SM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation | BMC molecular and cell biology |  | 2022 | 72 | 129 | ||
| GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation | Journal of cancer research and clinical oncology | | 2022 | 390 | 189 | ||
| Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT | Bone marrow transplantation |  | 2021 | 278 | 2 | ||
| Genetic Predictors for Sinusoidal Obstruction Syndrome - A Systematic Review | Journal of personalized medicine | | 2021 | 262 | 148 | ||
| The Catalytic Activity of GSTM1 In vitro is Independent of MAPK8 | Drug metabolism letters | | 2021 | 103 | 81 | ||
| A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma | Journal of experimental & clinical cancer research | | 2021 | 248 | 259 | ||
| The analysis of GSTA1 promoter genetic and functional diversity of human populations | Scientific reports | | 2021 | 280 | 273 | ||
| Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | | 2020 | 342 | 0 | ||
| The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review | International Journal of Molecular Sciences | | 2019 | 334 | 310 | ||
| PRIMA-1MET-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level | Journal of Experimental & Clinical Cancer Research | | 2019 | 319 | 423 | ||
| 11q deletion in neuroblastoma: a review of biological and clinical implications | Molecular Cancer | | 2017 | 491 | 351 |
